0001140361-14-040662.txt : 20141107 0001140361-14-040662.hdr.sgml : 20141107 20141107134220 ACCESSION NUMBER: 0001140361-14-040662 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141105 FILED AS OF DATE: 20141107 DATE AS OF CHANGE: 20141107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoey Timothy CENTRAL INDEX KEY: 0001553333 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 141203909 MAIL ADDRESS: STREET 1: C/O ONCOMED PHARMACEUTICALS, INC. STREET 2: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc1.xml FORM 4 X0306 4 2014-11-05 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001553333 Hoey Timothy C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 0 1 0 0 SVP, Cancer Biology Common Stock 2014-11-05 4 M 0 2500 1.43 A 52445 D Common Stock 2014-11-05 4 S 0 2500 19.5064 D 49945 D Stock Option (Right to Buy) 1.43 2014-11-05 4 M 0 2500 0.00 D 2017-01-10 Common Stock 2500 42763 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2013. Includes 602 shares acquired under the Issuer's Employee Stock Purchase Plan on August 29, 2014. This transaction was executed in multiple trades in prices ranging from $19.15 to $19.93, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The option is fully vested and exercisable, subject to a limitation of 175,438 shares that can be issued to a single grantee in a 12-month period upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan. /s/ Yvonne Li, Attorney-in-Fact for Timothy Hoey 2014-11-07